281 related articles for article (PubMed ID: 25471740)
1. Effect of concomitant icosapent ethyl (eicosapentaenoic acid ethyl ester) on the pharmacokinetics of atorvastatin.
Braeckman RA; Stirtan WG; Soni PN
Clin Drug Investig; 2015 Jan; 35(1):45-51. PubMed ID: 25471740
[TBL] [Abstract][Full Text] [Related]
2. Effect of icosapent ethyl (eicosapentaenoic acid ethyl ester) on omeprazole plasma pharmacokinetics in healthy adults.
Braeckman RA; Stirtan WG; Soni PN
Drugs R D; 2014 Sep; 14(3):159-64. PubMed ID: 24973042
[TBL] [Abstract][Full Text] [Related]
3. Effect of omega-3-acid ethyl esters on steady-state plasma pharmacokinetics of atorvastatin in healthy adults.
Di Spirito M; Morelli G; Doyle RT; Johnson J; McKenney J
Expert Opin Pharmacother; 2008 Dec; 9(17):2939-45. PubMed ID: 19006470
[TBL] [Abstract][Full Text] [Related]
4. Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Pharmacokinetic Parameters of Rosiglitazone in Healthy Subjects.
Braeckman RA; Stirtan WG; Soni PN
Clin Pharmacol Drug Dev; 2015 Mar; 4(2):143-148. PubMed ID: 26097794
[TBL] [Abstract][Full Text] [Related]
5. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
[TBL] [Abstract][Full Text] [Related]
6. Phase 1 study of the effect of icosapent ethyl on warfarin pharmacokinetic and anticoagulation parameters.
Braeckman RA; Stirtan WG; Soni PN
Clin Drug Investig; 2014 Jul; 34(7):449-56. PubMed ID: 24760401
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males.
Liu YM; Pu HH; Liu GY; Jia JY; Weng LP; Xu RJ; Li GX; Wang W; Zhang MQ; Lu C; Yu C
Clin Ther; 2010 Jul; 32(7):1396-407. PubMed ID: 20678686
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic Drug-Drug Interaction Study Between Raltegravir and Atorvastatin 20 mg in Healthy Volunteers.
Blonk M; van Beek M; Colbers A; Schouwenberg B; Burger D
J Acquir Immune Defic Syndr; 2015 May; 69(1):44-51. PubMed ID: 25942458
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers.
Teng R; Mitchell PD; Butler KA
Eur J Clin Pharmacol; 2013 Mar; 69(3):477-87. PubMed ID: 22922682
[TBL] [Abstract][Full Text] [Related]
10. Icosapent ethyl: Eicosapentaenoic acid concentration and triglyceride-lowering effects across clinical studies.
Bays HE; Ballantyne CM; Doyle RT; Juliano RA; Philip S
Prostaglandins Other Lipid Mediat; 2016 Sep; 125():57-64. PubMed ID: 27418543
[TBL] [Abstract][Full Text] [Related]
11. Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies.
Ballantyne CM; Bays HE; Philip S; Doyle RT; Braeckman RA; Stirtan WG; Soni PN; Juliano RA
Atherosclerosis; 2016 Oct; 253():81-87. PubMed ID: 27596132
[TBL] [Abstract][Full Text] [Related]
12. Effects of prescription omega-3-acid ethyl esters on non--high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin.
Bays HE; McKenney J; Maki KC; Doyle RT; Carter RN; Stein E
Mayo Clin Proc; 2010 Feb; 85(2):122-8. PubMed ID: 20118387
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of a fixed-dose combination of atorvastatin and metformin extended release versus concurrent administration of individual formulations: a randomized, open-label, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study.
Kandhwal K; Dey S; Nazarudheen S; Arora R; Reyar S; Thudi NR; Monif T; Singh MK; Rao S
Clin Drug Investig; 2011 Dec; 31(12):853-63. PubMed ID: 21919543
[TBL] [Abstract][Full Text] [Related]
14. Effect of itraconazole on the pharmacokinetics of atorvastatin.
Kantola T; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 1998 Jul; 64(1):58-65. PubMed ID: 9695720
[TBL] [Abstract][Full Text] [Related]
15. Effects of switching from omega-3-acid ethyl esters to icosapent ethyl in a statin-treated patient with elevated triglycerides.
Kedia AW; Lynch E
Postgrad Med; 2015; 127(8):869-73. PubMed ID: 26453247
[TBL] [Abstract][Full Text] [Related]
16. No clinically relevant drug-drug interactions when dalcetrapib is co-administered with atorvastatin.
Derks M; Abt M; Parr G; Meneses-Lorente G; Young AM; Phelan M
Expert Opin Investig Drugs; 2010 Oct; 19(10):1135-45. PubMed ID: 20738227
[TBL] [Abstract][Full Text] [Related]
17. Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites.
Backman JT; Luurila H; Neuvonen M; Neuvonen PJ
Clin Pharmacol Ther; 2005 Aug; 78(2):154-67. PubMed ID: 16084850
[TBL] [Abstract][Full Text] [Related]
18. Effects of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) on Atherogenic Lipid/Lipoprotein, Apolipoprotein, and Inflammatory Parameters in Patients With Elevated High-Sensitivity C-Reactive Protein (from the ANCHOR Study).
Miller M; Ballantyne CM; Bays HE; Granowitz C; Doyle RT; Juliano RA; Philip S
Am J Cardiol; 2019 Sep; 124(5):696-701. PubMed ID: 31277790
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic evaluation of the interaction between hepatitis C virus protease inhibitor boceprevir and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors atorvastatin and pravastatin.
Hulskotte EG; Feng HP; Xuan F; Gupta S; van Zutven MG; O'Mara E; Wagner JA; Butterton JR
Antimicrob Agents Chemother; 2013 Jun; 57(6):2582-8. PubMed ID: 23529734
[TBL] [Abstract][Full Text] [Related]
20. Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies.
Ballantyne CM; Bays HE; Braeckman RA; Philip S; Stirtan WG; Doyle RT; Soni PN; Juliano RA
J Clin Lipidol; 2016; 10(3):635-645.e1. PubMed ID: 27206952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
